1. Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland;
2. Translational Immunology Research Program, University of Helsinki, Helsinki, Finland;
3. iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland;
4. Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland;
5. Department of Pathology, HUSLAB and Haartman Institute, Helsinki University Hospital, University of Helsinki, Helsinki, Finland;
6. Novartis Pharmaceuticals, Basel, Switzerland;
7. Science for Life Laboratory, Department of Oncology and Pathology, Karolinska Institutet, Solna, Sweden; and
8. Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland